S100A8 and S100A9 in experimental osteoarthritis
Arthritis Research & Therapy2010Vol. 12(1), pp. R16–R16
Citations Over TimeTop 10% of 2010 papers
Hala Zreiqat, Daniele Belluoccio, Margaret M. Smith, Richard Wilson, Lynn Rowley, Katie Jones, Yogambha Ramaswamy, Thomas Vogl, Johannes Roth, John F. Bateman, Christopher B. Little
Abstract
Chondrocyte derived S100A8 and S100A9 may have a sustained role in cartilage degradation in inflammatory arthritis. In contrast, while these proteins may have a role in initiating early cartilage degradation in OA by upregulating MMPs and aggrecanases, their reduced expression in late stages of OA suggests they do not have an ongoing role in cartilage degradation in this non-inflammatory arthropathy.
Related Papers
- → S100A8 and S100A9 in inflammation and cancer(2006)703 cited
- → S100A8 and S100A9 in Cancer(2023)133 cited
- → Deletion of S100a8 and S100a9 Enhances Skin Hyperplasia and Promotes the Th17 Response in Imiquimod-Induced Psoriasis(2020)36 cited
- → The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: The S100A9 and S100A8 positive cells underlie and invade tumor mass(1999)102 cited